First regimen to treat all six major HCV genotypes The U.S. Food and Drug Administration approved Epclusa to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced liver disease). For patients with moderate
Read More...
Read the complete post at https://blog.aids.gov/2016/06/fda-approves-epclusa-for-treatment-of-chronic-hepatitis-c-virus-infection.html
Posted
Jun 30 2016, 07:00 AM
by
blog.aids.gov — HIV Policy & Programs. Research. New Media.